Abstract |
The soluble epoxide hydrolase (sEH) has been suggested as a pharmacological target for the treatment of several diseases, including pain-related disorders. Herein, we report further medicinal chemistry around new benzohomoadamantane-based sEH inhibitors (sEHI) in order to improve the drug metabolism and pharmacokinetics properties of a previous hit. After an extensive in vitro screening cascade, molecular modeling, and in vivo pharmacokinetics studies, two candidates were evaluated in vivo in a murine model of capsaicin-induced allodynia. The two compounds showed an anti-allodynic effect in a dose-dependent manner. Moreover, the most potent compound presented robust analgesic efficacy in the cyclophosphamide-induced murine model of cystitis, a well-established model of visceral pain. Overall, these results suggest painful bladder syndrome as a new possible indication for sEHI, opening a new range of applications for them in the visceral pain field.
|
Authors | Sandra Codony, José M Entrena, Carla Calvó-Tusell, Beatrice Jora, Rafael González-Cano, Sílvia Osuna, Rubén Corpas, Christophe Morisseau, Belén Pérez, Marta Barniol-Xicota, Christian Griñán-Ferré, Concepción Pérez, María Isabel Rodríguez-Franco, Antón L Martínez, M Isabel Loza, Mercè Pallàs, Steven H L Verhelst, Coral Sanfeliu, Ferran Feixas, Bruce D Hammock, José Brea, Enrique J Cobos, Santiago Vázquez |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 65
Issue 20
Pg. 13660-13680
(10 27 2022)
ISSN: 1520-4804 [Electronic] United States |
PMID | 36222708
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
|
Chemical References |
- Epoxide Hydrolases
- Urea
- Capsaicin
- Enzyme Inhibitors
- Analgesics
- Cyclophosphamide
|
Topics |
- Mice
- Humans
- Animals
- Epoxide Hydrolases
- Urea
(chemistry)
- Disease Models, Animal
- Visceral Pain
(chemically induced, drug therapy)
- Capsaicin
- Enzyme Inhibitors
(pharmacology)
- Analgesics
(pharmacology, therapeutic use)
- Cyclophosphamide
|